128 related articles for article (PubMed ID: 1973719)
1. Subpopulations of intrathyroidal lymphocytes in Graves' disease.
Duh YC; Su IJ; Liaw KY; Yao CC
J Formos Med Assoc; 1990 Feb; 89(2):121-5. PubMed ID: 1973719
[TBL] [Abstract][Full Text] [Related]
2. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
Paschke R; Vogg M; Swillens S; Usadel KH
J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
[TBL] [Abstract][Full Text] [Related]
3. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
4. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis.
Misaki T; Konishi J; Nakashima T; Iida Y; Kasagi K; Endo K; Uchiyama T; Kuma K; Torizuka K
Clin Exp Immunol; 1985 Apr; 60(1):104-10. PubMed ID: 3891164
[TBL] [Abstract][Full Text] [Related]
5. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease.
Fisfalen ME; DeGroot LJ; Quintans J; Franklin WA; Soltani K
J Clin Endocrinol Metab; 1988 Apr; 66(4):776-84. PubMed ID: 3257970
[TBL] [Abstract][Full Text] [Related]
6. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease.
Aust G; Lehmann I; Heberling HJ
Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571
[TBL] [Abstract][Full Text] [Related]
7. Immunological features of nonimmunogenic hyperthyroidism.
Grubeck-Loebenstein B; Derfler K; Kassal H; Knapp W; Krisch K; Liszka K; Smyth PP; Waldhäusl W
J Clin Endocrinol Metab; 1985 Jan; 60(1):150-5. PubMed ID: 2856880
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease.
Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Nakao H; Kawakami A; Izumi M
J Clin Endocrinol Metab; 1988 Nov; 67(5):1018-24. PubMed ID: 2972737
[TBL] [Abstract][Full Text] [Related]
10. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
Roman SH; Goldsmith NK; Leiderman IZ; Davies TF
Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
[TBL] [Abstract][Full Text] [Related]
11. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H
Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944
[TBL] [Abstract][Full Text] [Related]
12. Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands.
McLachlan SM; Pegg CA; Atherton MC; Middleton SL; Dickinson A; Clark F; Proctor SJ; Proud G; Rees Smith B
Clin Exp Immunol; 1986 Aug; 65(2):319-28. PubMed ID: 3791700
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
Ueki Y; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1987 Nov; 65(5):922-8. PubMed ID: 2959679
[TBL] [Abstract][Full Text] [Related]
14. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.
Ishikawa N; Eguchi K; Ueki Y; Nakashima M; Shimada H; Ito K; Nagataki S
Clin Exp Immunol; 1993 Nov; 94(2):363-70. PubMed ID: 7900942
[TBL] [Abstract][Full Text] [Related]
15. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
[TBL] [Abstract][Full Text] [Related]
16. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
18. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
[TBL] [Abstract][Full Text] [Related]
19. Graves' disease: in situ localization of lymphoid T cell subpopulations.
Bene MC; Derennes V; Faure G; Thomas JL; Duheille J; Leclere J
Clin Exp Immunol; 1983 May; 52(2):311-6. PubMed ID: 6345038
[TBL] [Abstract][Full Text] [Related]
20. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production.
Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
